Riso Pharmaceuticals International
Bioadvantex
Urixin
Silexin
Biolyse
Paclitaxel
BioSyent Inc.
FeraMAX
Feldan
Glenwood
Helsinn
Gelclair
Klean-Prep
Nasaleze Ltd.
Nasaleze
Omega laboratories
Pamidronate
PISA
Serral Laboratories
Stella Pharmaceutical Canada Inc.
Kolik-Gripe Water
Unigene
Fortical
 
Kolik-Gripe Water

 

Kolik Gripe Water for babies
Kolik - Gripe Water for babies

KOLIK is the First Alcohol-Free Gripe Water available

When lullabyes fail...
...the whole family might sleep better when you calm baby's digestive discomforts with Alcohol-Free KOLIK Gripe Water. A nursery standby, KOLIK provides fast, gentle pain relief from colic, cramps, flatulence, upset stomach, hiccoughs and other minor complaints.

Alcohol-Free Formulation

Although many products on the market contain a small amount of alcohol to solubilize and preserve the essential oils of the active ingredients, we recognize that some parents would prefer not to administer any preparation containing alcohol to their infants. For them, we have developed Alcohol-Free KOLIK Gripe Water. In this formulation, only purified water is used to extract the anti-gas and stomach-calming properties of natural source fennel oil, from fennel seed. Fennel has been a reliable remedy for centuries, as it helps relieve stomach pains and cramps due to gas.

This good-tasting preparation has a faint licorice flavour from the fennel oil.
Each teaspoonful (5 mL) contains:
  • Oil of Fennel 2.5 mg
  • Sodium Bicarbonate 50 mg

 
 

Riso Pharma Tech is a Canadian-based specialty pharmaceutical company focused on in-licensing late-stage and approved molecules for marketing and sales in Canada, certain European Union countries, Latin America, and the Middle East.

 

From large multi-national pharmaceutical companies to small biotechs, Riso's license deals have yielded successful product launches in its territories. Five regional offices and over 360 employees worldwide enable Riso to extend the reach of our partner companies' products.

 

With an extensive track record of greater than 10+ years marketing and sales success in its territories, and thanks to Riso's financial strength, Riso is aggressively pursuing new in-licensing opportunities across several therapeutic areas: oncology, supportive care, neurology, endocrinology and women's health.